Table 2 Effect sizes and p-values of significant CpG sites for each depression variable.
From: Association between maternal depression during pregnancy and newborn DNA methylation
A. Primary outcomes: Maternal depression scores and newborn DNAm | |||||
|---|---|---|---|---|---|
CpG Site | Chromosome: Position | Variable | Δ beta per IQRd | Standard Error | P-value |
cg16473797a | chr20:61755045 | EPDS Continuous | −1.06E-02 | 2.12E-04 | 1.04E-03 |
BDI-II Continuous | −5.64E-03 | 9.19E-05 | 5.72E-05 | ||
cg23262030a | chr17:45918702 | EPDS Continuous | 1.71E-03 | 4.21E-05 | 7.87E-03 |
BDI-II Continuous | 1.47E-03 | 1.82E-05 | 1.18E-07 | ||
cg04859497b | chr2: 79923818 | EPDS Continuous | −3.88E-02 | 1.05E-03 | 0.459 |
BDI-II Continuous | −2.85E-02 | 4.01E-04 | 3.61E-07 | ||
B. Secondary outcomes: Screening for maternal depression and newborn DNAm | |||||
CpG Site | Chromosome: Position | Variable | Δ betae | Standard Error | P-value |
cg16473797a | chr20:61755045 | EPDS Threshold 10 | −1.32E-03 | 1.55E-03 | 0.39 |
EPDS Threshold 13 | −7.09E-03 | 2.38E-03 | 2.38E-03 | ||
BDI-II Threshold 14 | −1.10E-02 | 2.04E-03 | 6.87E-08 | ||
BDI-II Threshold 20 | −8.61E-03 | 2.29E-03 | 1.72E-04 | ||
cg23262030a | chr17:45918702 | EPDS Threshold 10 | 6.94E-04 | 4.18E-04 | 9.7E-02 |
EPDS Threshold 13 | 1.06E-03 | 4.44E-04 | 1.7E-02 | ||
BDI-II Threshold 14 | 1.90E-03 | 4.10E-04 | 3.76E-06 | ||
BDI-II Threshold 20 | 1.40E-03 | 5.01E-04 | 5.01E-03 | ||
cg04859497b | chr2: 79923818 | EPDS Threshold 10 | −9.15E-03 | 1.00E-02 | 0.359 |
EPDS Threshold 13 | −8.34E-03 | 1.08E-02 | 0.437 | ||
BDI-II Threshold 14 | −3.25E-02 | 9.15E-03 | 3.84E-04 | ||
BDI-II Threshold 20 | −6.42E-02 | 1.05E-02 | 1.06E-09c | ||